Side of 1 slice whole grain toast
This trend raises concerns about physicians restricting GLP-1 prescriptions to the most severe cases of obesity, despite FDA approval for use in individuals with BMIs of 30 or higher, or 27 with a comorbidity
No tiered pricing structures, no dose-escalation surcharges, no insurance pre-authorizations that delay treatment for weeks
Rybelsus is available in three Health-Canada-approved dosages: 3mg, 7mg, and 14mg
Redundant mechanism, doubled GI side effects
#GLP1 #WeightManagement #DiabetesEducation #MetabolicHealth #HealthyWeightLoss #MuscleHealth #FunctionalMedicine #IntegrativeHealth #HolisticHealth #LivingHealth To view or add a comment, sign in Part 2 - Metabolic Health As of the most recent national estimates (20092016) only 12.2% or 1 in 8 US adults had optimal metabolic health (Arajo et al., 2019)